Key Trends Reshaping the Stem Cell Umbilical Cord Blood Market: Cord Blood Therapy Gains Approval For Long Covid Treatment Industry Transformation

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Stem Cell Umbilical Cord Blood Market Size Growth Forecast: What to Expect by 2025?
The size of the stem cell umbilical cord blood market has seen a swift expansion in recent times. The market's growth will escalate from $6.77 billion in 2024 to $7.98 billion in 2025, marking a compound annual growth rate (CAGR) of 17.8%. Factors that contributed to this growth during the historic period include rise in research and development activities, growing demand for private banking services, increase in the number of clinical trials, rising cancer cases, and growth in the number of fertility clinics.

How Will the Stem Cell Umbilical Cord Blood Market Size Evolve and Grow by 2029?
The market size for stem cell umbilical cord blood is forecasted to experience a significant surge in the upcoming years, targeting a growth to $15.21 billion in 2029 with a compound annual growth rate (CAGR) of 17.5%. This predicted boom during the forecast period can be tied to the escalating prevalence of chronic illnesses, a rise in birth rates, a surge in demand for stem cell treatments, favorable governmental policies and initiatives, and a growing emphasis on regenerative medicine. The forecast period will also witness notable trends like the evolution of therapeutic applications, the improvement in healthcare infrastructure, progress in cryopreservation techniques and a dovetailing with gene therapy.

View the full report here:
https://www.thebusinessresearchcompany.com/report/stem-cell-umbilical-cord-blood-global-market-report

What Drivers Are Propelling the Growth of Stem Cell Umbilical Cord Blood Market Forward?
The growth of the stem cell umbilical cord blood market is slated to surge due to rising childbirth rates. In essence, childbirth counts relate to live births per 1,000 individuals over a designated time frame, typically a year. Heightened childbirth rates attribute to the broader accessibility and affordability of fertility treatments, encouraging an increase in family expansion. The significance of umbilical cord blood stem cells comes into play for newborns, as these cells, rich in hematopoietic stem cells, can address a range of blood, immune, and genetic diseases. The cells are an exact genetic match for the newborn that could potentially assist siblings or other family members. Case in point, the U.S. Centers for Disease Control and Prevention, a federal agency based in the U.S., reported the number of births in the USA elevating from 3,596,017 in 2023 to 3,622,673 in 2024, indicating a 1% increase. Hence, the rise in childbirth rates catalyzes the expansion of the stem cell umbilical cord blood market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24715&type=smp

Which Emerging Trends Are Transforming the Stem Cell Umbilical Cord Blood Market in 2025?
Leading organizations in the umbilical cord blood stem cell market are zeroing in on formulating innovative treatments and garnering approval, such as cord blood cell treatment for rare genetic disorders, enhancement of immune system recovery, and bolstering applications in regenerative medicine. The therapy involving cord blood cells addresses several diseases using stem cells procured from umbilical cord blood, repairing damaged blood, immune, and other tissue systems. For instance, in October 2024, the US biotech firm, StemCyte, was granted the regenerative medicine advanced therapy designation from the U.S. FDA for its hematopoietic progenitor cell cord blood therapy (HPC Cord Blood) aimed at treating Long COVID-19 syndrome. This treatment employs cord blood cell therapy sourcing stem cells from umbilical cord blood to trigger healing and minimize inflammation. The method has projected potential in addressing immune-related and degenerating conditions, proposing a non-invasive and ethically sourced alternative for sophisticated regenerative treatments.

What Are the Key Segments in the Stem Cell Umbilical Cord Blood Market?
The stem cell umbilical cord blood market covered in this report is segmented -

1) By Product Type: Cord Blood Stem Cells, Cord Tissue Stem Cells
2) By Technology: Cryopreservation, Stem Cell Expansion, Cell Separation
3) By Storage Services: Public Cord Blood Banks, Private Cord Blood Banks, Hybrid Cord Blood Banks
4) By Application: Hematological Disorders, Metabolic Diseases, Immune System Disorders, Neurological Disorders, Other Applications
5) By End-User: Hospitals, Research Institutes, Biotechnology Companies, Other End-Users

Subsegments:
1) By Cord Blood Stem Cells: Hematopoietic Stem Cells, Mesenchymal Stem Cells, Endothelial Progenitor Cells, Regulatory T Cells, Natural Killer Cells, Dendritic Cells
2) By Cord Tissue Stem Cells: Mesenchymal Stem Cells, Epithelial Cells, Fibroblasts, Neural Progenitor Cells

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=24715&type=smp

Who Are the Key Players Shaping the Stem Cell Umbilical Cord Blood Market's Competitive Landscape?
Major companies operating in the stem cell umbilical cord blood market are Takeda Pharmaceutical Company Limited, Global Cord Blood Corporation, Vita 34 AG, Cordlife Group Limited, StemLife Berhad, MediPost Co. Ltd., Smart Cells International Ltd., StemCyte Inc., Celularity Inc., Next Biosciences Pty Ltd, Esperite N.V., Cryo-Cell International Inc., FamiCord Group, Cells4Life Group LLP, Cryoviva Biotech Pvt. Ltd., Americord Registry LLC, ViaCord LLC, China Cord Blood Corporation, CBR Systems Inc., Cord Blood Registry.

What Geographic Markets Are Powering Growth in the Stem Cell Umbilical Cord Blood Market?
North America was the largest region in the stem cell umbilical cord blood market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the stem cell umbilical cord blood market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24715

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.